Management of inflammatory neuropathies

Neurology in Practice

Volumn 74, Issue 2, 2003, Pages

  Hadden, Robert D M ^a   Hughes, Richard A C ^b  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA INTERFERON; AMITRIPTYLINE; ANALGESIC AGENT; AZATHIOPRINE; BETA1A INTERFERON; CARBAMAZEPINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; FLUDARABINE; FRESH FROZEN PLASMA; GABAPENTIN; IMMUNOGLOBULIN; INFLUENZA VACCINE; MELPHALAN; MEPREDNISONE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARAPROTEIN; PREDNISOLONE; RITUXIMAB; SILDENAFIL; TACROLIMUS; TETANUS TOXOID; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLADDER DISEASE; BONE MARROW TOXICITY; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL TRIAL; DEMYELINATING NEUROPATHY; DIARRHEA; EDEMA; GONADAL DISEASE; GUILLAIN BARRE SYNDROME; HIRSUTISM; HUMAN; HYPERTENSION; HYPOTENSION; INFECTION; LEUKOPENIA; NAUSEA; NEOPLASM; NEPHROTOXICITY; NEUROPATHY; PARAPROTEINEMIA; PLASMAPHERESIS; PRIORITY JOURNAL; RASH; REVIEW; SIDE EFFECT; STEM CELL TRANSPLANTATION; ANTIBODY BLOOD LEVEL; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COUNSELING; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY DISEASE; NERVE CONDUCTION; NEUROPHYSIOLOGY; OCCUPATIONAL THERAPY; PERIPHERAL NERVE; PODIATRY;

ANTI-INFLAMMATORY AGENTS; BLOOD PROTEIN ELECTROPHORESIS; DIAGNOSIS, DIFFERENTIAL; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MILLER FISHER SYNDROME; NEURAL CONDUCTION; PARAPLEGIA; PARAPROTEINEMIAS; PLASMA EXCHANGE; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; RANDOMIZED CONTROLLED TRIALS; STEROIDS;

EID: 0038692413     PISSN: 14737086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-4. GBS diagnostic criteria.
2. Cornblath DR (Rapporteur). Acute onset flaccid paralysis. WHO-AIREN/MNH/EPI/93.3, Geneva, 1993
3. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577-95. The different neuropathologies underlying the syndrome of GBS.
4. Jacobs BC, Rothbarth PH, Van der Meché FGA, et al. The spectrum of antecedent infections in Guillain-Barré syndrome. A case control study. Neurology 1998;51:1110-15. The largest study of the infections preceding GBS.
5. Willison HJ, Yuki N. Peripheral neuropathies and antiglycolipid antibodies. Brain 2002;125:2591-625. Anti-ganglioside antibodies, molecular mimicry, and pathogenesis of subtypes of inflammatory neuropathy.
6. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985;6:504-9. The most detailed description of the neurophysiological changes in GBS over time.
7. Raphaël JC, Chevret S, Hughes RAC, et al. Plasma exchange for Guillain-Barré syndrome (Cochrane Review). In: The Cochrane Library, 2002. Oxford: Update Software.
8. Hughes RAC, Raphaël JC, Swan AV, et al. Intravenous immunoglobulin for Guillain-Barré syndrome (Cochrane Review). In: The Cochrane Library, 2002. Oxford: Update Software.
9. Van Schaik IN, Winer JB, de Haan R, et al. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy (Cochrane Review). In: The Cochrane Library, 2002. Oxford: Update Software.